Skip to main content Skip to section navigation Skip to footer
chevron_leftBack to www.corbuspharma.com
Corbus Pharmaceuticals Holdings, Inc. IR Overview
  • Investors
  • Presentations
  • Analyst Coverage
  • News / Events
    • Press Releases
    • Events
  • Company Information
    • Profile
    • IR Contacts
    • FAQ
  • Financial Information
    • Financial Results
  • Stock Data
    • Quote and Chart
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • chevron_leftBack to www.corbuspharma.com

Press Releases

News / Events

News / Events

  • Press Releases
  • Events
Apr 18, 2023 • 8:00 am EDT
Corbus Pharmaceuticals Hosting Virtual 'Meet the Expert' Series: Blocking TGFβ with CRB-601--a New Play for an Old Target
Apr 17, 2023 • 8:30 am EDT
Corbus Pharmaceuticals Presents Latest Pre-Clinical Data on CRB-601 at the 2023 American Association for Cancer Research Annual Meeting
Mar 14, 2023 • 4:35 pm EDT
Corbus Pharmaceuticals Data on CRB-601 avβ8 Blocking Antibody Accepted for Presentation at the America Association for Cancer Research Annual Meeting
Mar 7, 2023 • 8:00 am EST
Corbus Pharmaceuticals Reports Fourth Quarter 2022 and Year-End Financial Results and Provides Corporate Update
Mar 6, 2023 • 8:00 am EST
Corbus Pharmaceuticals Expands Board of Directors with Appointment of Yong Ben, M.D., MBA
Mar 2, 2023 • 8:00 am EST
Corbus Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference
Feb 13, 2023 • 6:55 am EST
Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC)
Nov 10, 2022 • 9:05 am EST
Corbus Presents Latest Preclinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
Nov 8, 2022 • 8:05 am EST
Corbus Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Oct 14, 2022 • 8:05 am EDT
Corbus Pharmaceuticals to Present Pre-Clinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • …
  • Page 29
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
©2025 Corbus Pharmaceuticals Holdings, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement